Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening
Open Access
- 12 August 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 13030
Abstract
Matrix metalloproteinase-9 (MMP-9) is related to tumour development and progression in colorectal cancer (CRC) and its utility as biomarker has been suggested. The aim of our study was to measure serum MMP-9 in asymptomatic first-degree relatives of CRC patients and to analyse its diagnostic accuracy for the detection of advanced neoplasia (AN: advanced adenomas and CRC). Additionally, we compared its diagnostic capability with the most used non-invasive faecal immunochemical test (FIT). Serum MMP-9 was quantified by ELISA in 516 asymptomatic individuals that underwent a colonoscopy and a FIT. MMP-9 levels were significantly related to age and gender and therefore the concentration was corrected by these confounders. Corrected MMP-9 (cMMP-9) levels were higher in individuals with advanced adenomas (AA; p-value = 0.029) and AN (p-value = 0.056) compared to individuals with no neoplasia. Moreover, elevated cMMP-9 concentration was associated with more severe characteristics of adenomas (number of lesions, size and histology). Nevertheless, the diagnostic accuracy of cMMP-9 was considerably lower than that of FIT for identifying AA (22.64% vs. 47.17% sensitivity, 90% specificity) or AN (19.30% vs. 52.63% sensitivity, 90% specificity). According to our results, serum MMP-9 cannot be considered of utility for the diagnosis of AN in CRC family-risk population screening.Keywords
This publication has 35 references indexed in Scilit:
- The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal CancerInternational Journal of Molecular Sciences, 2012
- Progressive Increase of Matrix Metalloprotease-9 and Interleukin-8 Serum Levels during Carcinogenic Process in Human Colorectal TractPLOS ONE, 2012
- Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort studyBMC Gastroenterology, 2012
- Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic testBritish Journal of Cancer, 2012
- The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patientsInternational Journal of Colorectal Disease, 2010
- Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human CancerJournal of Clinical Oncology, 2009
- Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patientsBritish Journal of Cancer, 2007
- Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancerGut, 2007
- Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequenceEuropean Journal of Cancer, 2006
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002